Drug intelligence / Profile preview

AcuPlus

Development stage: Unknown
Lead developer: Innovations for Wellness
Modality: Small Molecules
Administration: Topical

Overview

**AcuPlus** is a marketed over-the-counter topical analgesic product from Innovations for Wellness. Its labeled active ingredient is menthol 3.5%, supplied as a cream for external topical use. Menthol produces a cooling counterirritant analgesic effect and is indicated for temporary relief of minor muscle and joint aches associated with arthritis, simple backache, strains, bruises, and sprains. The formula also includes supportive non-active ingredients such as aloe, arnica, MSM, glucosamine, magnesium sulfate, and vitamins. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7f222a4f-85a8-4f3d-aa97-5c695d4da37f))

Brand names: AcuPlusAcuPlus Pain Relief

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on AcuPlus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AcuPlus.

Explore the full profile